Mucosal vaccination of the newborn: An unrealized opportunity

Expert Review of Vaccines

Volumn 8, Issue 1, 2009, Pages 1-3

  Griebel, Philip J ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; IMMUNOGLOBULIN A; VIRUS VACCINE;

ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG RESPONSE; EDITORIAL; HUMAN; IMMUNOCOMPETENCE; IMMUNOLOGICAL MEMORY; LYMPHOID TISSUE; MUCOSA ASSOCIATED LYMPHOID TISSUE; MUCOSAL IMMUNITY; MUCOSAL VACCINATION; NEWBORN; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; VACCINATION;

ANIMALS; HUMANS; IMMUNITY, MUCOSAL; INFANT, NEWBORN; MICE; SHEEP; VACCINATION; VACCINES;

EID: 58149384061     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.8.1.1     Document Type: Editorial

References (27)

1. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7, 379-390 (2007).
2. Maródi L. Innate cellular immune responses in newborns. Clin. Immunol. 118, 137-144 (2006).
3. Siegrist CA. The challenges of vaccine responses in early life: selected examples. J. Comp. Pathol. 137, S4-S9 (2007).
4. Chase CCL, Hurley DJ, Reber AJ. Neonatal immune development in the calf and its impact on vaccine response. Vet. Clin. North Am. Food Anim. Pract. 24, 87-104 (2007).
5. Van Drunen Littel-Van Den Hurk S, Braun RP, Lewis PJ et al. Immunization of neonates with DNA encoding a bovine herpesvirus glycoprotein is effective in the presence of maternal antibodies. Viral Immunol. 12, 67-77 (1999).
6. Gerdts V, Babiuk LA, van Drunen Littel-van den Hurk S, Griebel PJ. Fetal immunization by a DNA vaccine delivered orally into the amniotic fluid. Nat. Med. 6, 929-932 (2000).
7. Gerdts V, Snider M, Brownlie R et al. Oral DNA immunisation in utero induces mucosal immunity and immune memory in the neonate. J. Immunol. 168, 1877-1885 (2002).
8. Mutwiri G, Bateman C, Baca-Estrada ME et al. Induction of immune responses in newborn lambs following enteric immunization with a human adenovirus vaccine vector. Vaccine 19, 1284-1293 (2001).
9. Avakian AP, Poston RM, Kong FK et al. Automated mass immunization of poultry: the prospect for nonreplicating human adenovirus-vectored in ovo vaccines. Expert Rev. Vaccines 6, 457-465 (2007).
10. Williams RC, Gibbons RJ. Inhibition of bacterial adherence by secretory immunoglobulin A: a mechanism of antigen disposal. Science 177, 697-699 (1972).
11. Fubara ES, Freter R. Protection against enteric bacterial infection by secretory IgA antibodies. J. Immunol. 111, 395-403 (1973).
12. Winner L, Mack J, Weltzin R et al. New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection. Infect. Immun. 59, 977-982 (1991).
13. Waksman BH, Ozer H. Specialized amplification elements in the immune system. The role of nodular lymphoid organs in the mucous membranes. Prog. Allergy 21, 1-10 (1976).
14. Husband AJ, Gowans JL. The origin and antigen-dependent distribution of IgA-containing cells in the intestine. J. Exp. Med. 148, 1146-1160 (1978).
15. Tomasi TB. The Immune System of Secretions. Prectice-Hall, Englewood Cliffs, NJ, USA (1976).
16. Waldman RH, Ganguly R. Immunity to infections on secretory surfaces. J. Infect. Dis. 130, 419-440 (1974).
17. McGhee JR, Mestecky J. In defense of mucosal surfaces. Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens. Infect. Dis. Clin. North Am. 4, 315-341 (1990).
18. Ferguson A, Parrott DMV. The effect of antigen deprivation on thymus-dependent and thymus-independent lymphocytes in the small intestine of the mouse. Clin. Exp. Immunol. 12, 477-488 (1972).
19. Pollard M, Sharon N. Responses of the Peyer's patches in germ-free mice to antigenic stimulation. Infect. Immun. 2, 96-100 (1970).
20. Cornes JS. Number, size, and distribution of Peyer's patches in the human small intestine: part I. The development of Peyer's patches. Gut 6, 225-229 (1965).
21. Griebel PJ, Hein WR. Expanding the role of Peyer's patches in B-cell ontogeny. Immunol. Today 17, 30-38 (1996).
22. Schepper R. Intranasal 5 way plus Pasteurella vaccine. Calf Talk 14, 7 (2008).
23. Silin DS, Lyubomska OV, Jirathitikal V, Bourinbaiar AS. Oral vaccination: where we are? Expert Opin. Drug Deliv. 4, 323-340 (2007).
24. Takahashi Y. Memory B cells in systemic and mucosal immune response: implications for successful vaccination. Biosci. Biotechnol. Biochem. 71, 2358-2366 (2007).
25. Tsang C, Babiuk S, van Drunen Littel-van den Hurk S et al. A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months. Vaccine 25, 5485-5494 (2007).
26. Mutwiri G, Watts T, Lew L et al. Ileal and jejunal Peyer's patches play distinct roles in mucosal immunity of sheep. Immunology 97, 455-461 (1999).
27. Van Kruiningen HJ, Ganley LM, Fredda BJ. The role of Peyer's patches in the age-related incidence of Crohn's disease. J. Clin. Gastroenterol. 24, 470-475 (1997).